BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 10146586)

  • 1. Advances in the prevention of venous thromboembolic disease in orthopaedics: the introduction of LMWH.
    Colwell CW; Paiement G; Pellegrini VD; Salvati EA; Stulberg BN
    Contemp Orthop; 1993 Dec; 27(6):551-77. PubMed ID: 10146586
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin: from the bench to the orthopedic patient.
    Turpie AG
    Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the risk of venous thromboembolism in orthopedics: concluding remarks.
    Haas S
    Orthopedics; 1997 Feb; 20 Suppl():26-7. PubMed ID: 9048405
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 6. [New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
    Sureda A; García Frade LJ; Navarro JL
    Sangre (Barc); 1990 Oct; 35(5):389-96. PubMed ID: 1963241
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of post-operative thrombosis by low molecular weight heparin in patients undergoing hip replacement.
    Thomas DP
    Thromb Haemost; 1992 May; 67(5):491-3. PubMed ID: 1325677
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombosis in trauma and orthopedic surgery. Prevention, diagnosis, therapy].
    Haas S
    Unfallchirurg; 1997 Apr; 100(4):307-19. PubMed ID: 9229783
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of postoperative thromboembolism after major orthopedic operations].
    Luger E; Arbel R; Dekel S
    Harefuah; 1992 Jan; 122(1):39-43. PubMed ID: 1551613
    [No Abstract]   [Full Text] [Related]  

  • 13. The Otto Aufranc Award paper. New advances in the prevention, diagnosis, and cost effectiveness of venous thromboembolic disease in patients with total hip replacement.
    Paiement GD; Bell D; Wessinger SJ; Harris WH
    Hip; 1987; ():94-119. PubMed ID: 3102409
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing the risk of venous thromboembolism in orthopedics: introductory remarks.
    Fitzgerald RH
    Orthopedics; 1997 Feb; 20 Suppl():6. PubMed ID: 9048399
    [No Abstract]   [Full Text] [Related]  

  • 15. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis of venous thromboembolism in surgery.
    Verhaeghe R; Verstraete M
    Acta Chir Belg; 1997 Jun; 97(3):106-9. PubMed ID: 9224512
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of thromboembolic diseases in orthopedics and traumatology using low molecular weight heparins].
    Barsotti J; Rosset P; Planes A; Marchal C; Robert C
    Rev Chir Orthop Reparatrice Appar Mot; 1992; 78 Suppl 1():229-34. PubMed ID: 1339122
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
    Agnelli G; Cimminiello C
    Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of postoperative venous thromboembolic complications].
    Savel'ev VS; Gologorskiĭ VA; Kirienko AI; Gel'fand BR
    Anesteziol Reanimatol; 2000; (4):68-71. PubMed ID: 11014003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.